The influence of cyclin D1 (CCND1) 870A>G polymorphism and CCND1-thymidylate synthase (TS) gene???gene interaction on the outcome of childhood acute lymphoblastic leukaemia
- 1 September 2003
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pharmacogenetics
- Vol. 13 (9), 577-580
- https://doi.org/10.1097/00008571-200309000-00006
Abstract
The 870A>G polymorphism in the cyclin D1 (CCND1) gene modulates mRNA splicing, leading to altered protein that may affect the regulation of the G1/S cell-cycle checkpoint. This polymorphism has been reported to influence susceptibility to and progression of several malignancies. Furthermore, the change of retinoblastoma protein regulation mediated by CCND1 may play a role in the development of methotrexate (MTX) resistance via an associated higher activity of enzymes that are inhibited by MTX. This study shows that children with acute lymphoblastic leukaemia (ALL) who are homozygous for the CCND1 A variant have a lower probability of event-free survival (P = 0.006) compared to carriers of the G variant. A significant result is retained in the presence of other prognostic factors. This impact is even more apparent in individuals who are also homozygous for thymidylate synthase (TS) triple repeat (PKeywords
This publication has 12 references indexed in Scilit:
- Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemiaBlood, 2002
- Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemiaThe Lancet, 2002
- Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.Carcinogenesis: Integrative Cancer Research, 2002
- Childhood acute lymphoblastic leukaemia – current status and future perspectivesThe Lancet Oncology, 2001
- Genetic Polymorphism of Thiopurine S-Methyltransferase: Molecular Mechanisms and Clinical ImportancePharmacology, 2000
- Diagnostic and Prognostic Significance of Chromosome Abnormalities in Childhood Acute Lymphoblastic LeukemiaAnnals of the New York Academy of Sciences, 1997
- Intrinsic and Acquired Resistance to Methotrexate in Acute LeukemiaNew England Journal of Medicine, 1996
- Effect of Cyclin D1 Overexpression on Drug Sensitivity in a Human Fibrosarcoma Cell LineJNCI Journal of the National Cancer Institute, 1996
- Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphismCancer Letters, 1995